BIOASTER Awarded Grant to Develop Multiplex Rapid Diagnostics for Neglected Tropical Diseases Plaguing Millions Globally

Press Release BIOASTER 30th June



Onchocerciasis, also known as river blindness, stands as the second leading cause of infectious blindness worldwide. According to estimates by the World Health Organization (WHO), approximately 25 million people are infected globally, with another 90 million at risk. Over 99% of these cases occur in Africa, and vision loss affects around 1.15 million individuals. The primary strategy for combating onchocerciasis currently is Community Directed Treatment with Ivermectin (CDTI), requiring a minimum of 80% therapeutic coverage for 10 -15 years.

Download the full Press Release HERE.

See our other Grants & EU project: